Since the silencing of the gene expression for GHRH lasts only for limited cell passages, the western blots of the proteins obtained in late cell passages show that the silencing of the GHRH gene expression was less effective for the two breast cancer cell lines in these passages (28 and 64% respectively). The gene discussed is GHRH; the disease is breast cancer.